RecallDepth
Class II Ongoing

Duloxetine Delayed-Release Capsules, USP, 30 mg, Rx only, a) 30 count (NDC 68001-414-04) and b) 1,000 count (NDC 68001-414-08) bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories

This recall is currently active, issued December 11, 2024. It was issued by Amerisource Health Services Llc.

Company
Amerisource Health Services Llc
Recall Initiated
November 14, 2024
Posted
December 11, 2024
Recall Number
D-0100-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
23,490 bottles
Firm Location
Columbus, OH, United States
Official Source
View on FDA website ↗

Reason for Recall

CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit

Distribution

PA, OH, PR

Lot / Code Info

a) 30 count; Lot, expiry: DT3023019B, DT3023020A, exp 01/31/2025 b) 1000 count; Lot, expiry: DTB23098A, exp 08/31/2025

More recalls by Amerisource Health Services Llc

View all recalls by this company →

Other recent Class II Drug recalls